Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
Clinical trial NCT02237937 · UNKNOWN
Trial details
- NCT number
- NCT02237937
- Sponsor
- HolsboerMaschmeyer NeuroChemie GmbH
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.